Intravitreal Bevacizumab in a Patient With Neovascular Glaucoma
- 1 March 2006
- journal article
- Published by SLACK, Inc. in Ophthalmic Surgery, Lasers and Imaging Retina
- Vol. 37 (2) , 144-146
- https://doi.org/10.3928/1542-8877-20060301-11
Abstract
Ophthalmic Surgery, Lasers and Imaging Retina | The utility of intravitreal bevacizumab injection in a patient with neovascular glaucoma following central retinal vein occlusion is explored. Bevacizumab (1 mg in 0.04 mL) was used after failed intraocular pressure (IOP) control with transscleral cyclophotocoagulation and panretinal photocoagulation. IOP improved within 2 days and the patient experienced marked improvement in comfort.Keywords
This publication has 6 references indexed in Scilit:
- Intravitreal Bevacizumab for Choroidal Neovascularization and Cystoid Macular Edema: A Cost-Effective Treatment?Ophthalmic Surgery, Lasers and Imaging Retina, 2005
- Optical Coherence Tomography Findings After an Intravitreal Injection of Bevacizumab (Avastin®) for Neovascular Age-Related Macular DegenerationOphthalmic Surgery, Lasers and Imaging Retina, 2005
- Optical Coherence Tomography Findings After an Intravitreal Injection of Bevacizumab (Avastin®) for Macular Edema From Central Retinal Vein OcclusionOphthalmic Surgery, Lasers and Imaging Retina, 2005
- Systemic Bevacizumab (Avastin) Therapy for Neovascular Age-Related Macular DegenerationTwelve-Week Results of an Uncontrolled Open-Label Clinical StudyOphthalmology, 2005
- Vitreous Levels of Vascular Endothelial Growth Factor and Intercellular Adhesion Molecule 1 Are Related to Diabetic Macular EdemaOphthalmology, 2005
- Phase II, Randomized Trial Comparing Bevacizumab Plus Fluorouracil (FU)/Leucovorin (LV) With FU/LV Alone in Patients With Metastatic Colorectal CancerJournal of Clinical Oncology, 2003